← Evidence map

ArticleMicroorganisms2024

Challenges in Diagnosis of COVID-19 Pneumonia under Ocrelizumab and De-Risking Strategies in Multiple Sclerosis-The Elephant Is (Still) in the Room.

Alice Mariottini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Challenges in Diagnosis of COVID-19 Pneumonia under Ocrelizumab and De-Risking Strategies in Multiple Sclerosis-The Elephant Is (Still) in the Room. | OpenQuestion